PIERIS PHARMACEUTICALS INC's ticker is PIRS and the CUSIP is 720795103. A total of 96 filers reported holding PIERIS PHARMACEUTICALS INC in Q1 2020. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $4,320 | -98.7% | 26,100 | -92.6% | 0.00% | -100.0% |
Q1 2023 | $342,072 | -4.4% | 350,484 | +1.9% | 0.01% | -15.4% |
Q4 2022 | $357,691 | -1.5% | 343,934 | +9.0% | 0.01% | -7.1% |
Q3 2022 | $363,000 | -38.5% | 315,634 | +0.1% | 0.01% | -33.3% |
Q2 2022 | $590,000 | -46.0% | 315,384 | -12.6% | 0.02% | -36.4% |
Q1 2022 | $1,093,000 | -19.5% | 360,834 | +0.4% | 0.03% | -13.2% |
Q4 2021 | $1,358,000 | -27.9% | 359,234 | -1.4% | 0.04% | -33.3% |
Q3 2021 | $1,884,000 | +36.7% | 364,484 | +1.3% | 0.06% | +39.0% |
Q2 2021 | $1,378,000 | +127.8% | 359,800 | +52.7% | 0.04% | +115.8% |
Q1 2021 | $605,000 | +4.3% | 235,600 | +1.6% | 0.02% | -5.0% |
Q4 2020 | $580,000 | +26.9% | 231,900 | +4.9% | 0.02% | +11.1% |
Q3 2020 | $457,000 | -18.8% | 221,000 | +21.8% | 0.02% | -28.0% |
Q2 2020 | $563,000 | +160.6% | 181,500 | +91.6% | 0.02% | +92.3% |
Q1 2020 | $216,000 | – | 94,750 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Lynx1 Capital Management LP | 5,628,585 | $5,853,728 | 5.06% |
Aquilo Capital Management, LLC | 4,552,876 | $4,734,991 | 1.78% |
BVF INC/IL | 5,080,320 | $5,283,533 | 0.22% |
Soleus Capital Management, L.P. | 1,000,000 | $1,040,000 | 0.15% |
Cutter & CO Brokerage, Inc. | 378,479 | $393,618 | 0.13% |
PLATINUM INVESTMENT MANAGEMENT LTD | 1,220,798 | $1,269,630 | 0.05% |
GSA CAPITAL PARTNERS LLP | 365,047 | $380 | 0.05% |
Annandale Capital, LLC | 67,000 | $70 | 0.02% |
WEALTH EFFECTS LLC | 21,700 | $22,568 | 0.01% |
Sigma Planning Corp | 343,934 | $357,691 | 0.01% |